

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma lipoprotein particle assembly (GO:0034377) | 7.31835202 |
| 2 | very-low-density lipoprotein particle assembly (GO:0034379) | 7.16278777 |
| 3 | alanine transport (GO:0032328) | 6.62738813 |
| 4 | regulation of penile erection (GO:0060405) | 6.43253556 |
| 5 | protein-lipid complex assembly (GO:0065005) | 6.28885147 |
| 6 | intestinal cholesterol absorption (GO:0030299) | 6.13791911 |
| 7 | protein carboxylation (GO:0018214) | 5.98320053 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.98320053 |
| 9 | regulation of cholesterol esterification (GO:0010872) | 5.93796710 |
| 10 | high-density lipoprotein particle remodeling (GO:0034375) | 5.81665824 |
| 11 | negative regulation of fibrinolysis (GO:0051918) | 5.76759095 |
| 12 | plasma lipoprotein particle remodeling (GO:0034369) | 5.62512828 |
| 13 | protein-lipid complex remodeling (GO:0034368) | 5.62512828 |
| 14 | macromolecular complex remodeling (GO:0034367) | 5.62512828 |
| 15 | reverse cholesterol transport (GO:0043691) | 5.60332508 |
| 16 | cholesterol efflux (GO:0033344) | 5.60238560 |
| 17 | proline transport (GO:0015824) | 5.50117672 |
| 18 | plasma lipoprotein particle organization (GO:0071827) | 5.24988588 |
| 19 | cell communication by electrical coupling (GO:0010644) | 5.22599147 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.22370074 |
| 21 | cGMP-mediated signaling (GO:0019934) | 5.12735784 |
| 22 | regulation of fever generation (GO:0031620) | 5.00104804 |
| 23 | L-serine transport (GO:0015825) | 4.89591509 |
| 24 | protein-lipid complex subunit organization (GO:0071825) | 4.81370171 |
| 25 | plasma lipoprotein particle clearance (GO:0034381) | 4.78536383 |
| 26 | vascular smooth muscle contraction (GO:0014829) | 4.75682991 |
| 27 | regulation of protein activation cascade (GO:2000257) | 4.65152804 |
| 28 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.64781840 |
| 29 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.55682884 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 4.55358786 |
| 31 | regulation of heat generation (GO:0031650) | 4.54932551 |
| 32 | positive regulation of renal sodium excretion (GO:0035815) | 4.52109814 |
| 33 | regulation of complement activation (GO:0030449) | 4.50941807 |
| 34 | blood coagulation, intrinsic pathway (GO:0007597) | 4.43768565 |
| 35 | regulation of apoptotic cell clearance (GO:2000425) | 4.38125572 |
| 36 | cellular potassium ion homeostasis (GO:0030007) | 4.31626421 |
| 37 | phospholipid efflux (GO:0033700) | 4.26510619 |
| 38 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.26319762 |
| 39 | negative regulation of adenylate cyclase activity (GO:0007194) | 4.19752246 |
| 40 | regulation of bile acid biosynthetic process (GO:0070857) | 4.11767669 |
| 41 | negative regulation of cholesterol transport (GO:0032375) | 4.08156001 |
| 42 | negative regulation of sterol transport (GO:0032372) | 4.08156001 |
| 43 | serine transport (GO:0032329) | 4.07101993 |
| 44 | intestinal absorption (GO:0050892) | 4.01686405 |
| 45 | cellular sodium ion homeostasis (GO:0006883) | 3.98938747 |
| 46 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 3.98841417 |
| 47 | negative regulation of cyclase activity (GO:0031280) | 3.98416691 |
| 48 | sodium ion export (GO:0071436) | 3.97167303 |
| 49 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.87951661 |
| 50 | L-phenylalanine catabolic process (GO:0006559) | 3.87951661 |
| 51 | negative regulation of lyase activity (GO:0051350) | 3.82932225 |
| 52 | potassium ion import (GO:0010107) | 3.81293187 |
| 53 | enteric nervous system development (GO:0048484) | 3.79828365 |
| 54 | Golgi transport vesicle coating (GO:0048200) | 3.78602908 |
| 55 | COPI coating of Golgi vesicle (GO:0048205) | 3.78602908 |
| 56 | regulation of cholesterol homeostasis (GO:2000188) | 3.77109907 |
| 57 | phasic smooth muscle contraction (GO:0014821) | 3.76954425 |
| 58 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.75981993 |
| 59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.71003300 |
| 60 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.70024190 |
| 61 | atrial cardiac muscle cell action potential (GO:0086014) | 3.65174593 |
| 62 | regulation of plasminogen activation (GO:0010755) | 3.64879338 |
| 63 | positive regulation of hormone metabolic process (GO:0032352) | 3.60373079 |
| 64 | cholesterol homeostasis (GO:0042632) | 3.60312911 |
| 65 | neurotransmitter uptake (GO:0001504) | 3.57031116 |
| 66 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.55583805 |
| 67 | sterol homeostasis (GO:0055092) | 3.54800422 |
| 68 | cholesterol biosynthetic process (GO:0006695) | 3.52436525 |
| 69 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.51445710 |
| 70 | sterol transport (GO:0015918) | 3.50689013 |
| 71 | cholesterol transport (GO:0030301) | 3.50689013 |
| 72 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.50100722 |
| 73 | nitric oxide mediated signal transduction (GO:0007263) | 3.47757637 |
| 74 | negative regulation of cAMP biosynthetic process (GO:0030818) | 3.46890580 |
| 75 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.44207577 |
| 76 | membrane repolarization (GO:0086009) | 3.43211108 |
| 77 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.42796544 |
| 78 | lipoprotein metabolic process (GO:0042157) | 3.41964340 |
| 79 | regulation of membrane repolarization (GO:0060306) | 3.39616260 |
| 80 | L-phenylalanine metabolic process (GO:0006558) | 3.38521810 |
| 81 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.38521810 |
| 82 | regulation of cell maturation (GO:1903429) | 3.36372711 |
| 83 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.36079698 |
| 84 | proline metabolic process (GO:0006560) | 3.34493648 |
| 85 | artery smooth muscle contraction (GO:0014824) | 3.34403814 |
| 86 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 3.33165840 |
| 87 | peptidyl-glutamic acid modification (GO:0018200) | 3.33066662 |
| 88 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.32400412 |
| 89 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.29861152 |
| 90 | regulation of renal sodium excretion (GO:0035813) | 3.29787246 |
| 91 | C4-dicarboxylate transport (GO:0015740) | 3.25135490 |
| 92 | peptide hormone processing (GO:0016486) | 3.25106911 |
| 93 | acylglycerol homeostasis (GO:0055090) | 3.25102798 |
| 94 | triglyceride homeostasis (GO:0070328) | 3.25102798 |
| 95 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.23113627 |
| 96 | negative regulation of sodium ion transport (GO:0010766) | 3.22298099 |
| 97 | vasodilation (GO:0042311) | 3.22175757 |
| 98 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.22054411 |
| 99 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.21955514 |
| 100 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.20983260 |
| 101 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.20087321 |
| 102 | trivalent inorganic anion homeostasis (GO:0072506) | 3.19076338 |
| 103 | phosphate ion homeostasis (GO:0055062) | 3.19076338 |
| 104 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.18309046 |
| 105 | negative regulation of protein activation cascade (GO:2000258) | 3.18287019 |
| 106 | negative regulation of lipase activity (GO:0060192) | 3.16929910 |
| 107 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.15231770 |
| 108 | diacylglycerol metabolic process (GO:0046339) | 3.14851899 |
| 109 | regulation of beta-amyloid formation (GO:1902003) | 3.14143631 |
| 110 | positive regulation of steroid metabolic process (GO:0045940) | 3.14110364 |
| 111 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.13972213 |
| 112 | negative regulation of cAMP metabolic process (GO:0030815) | 3.13888532 |
| 113 | potassium ion homeostasis (GO:0055075) | 3.13851315 |
| 114 | transepithelial transport (GO:0070633) | 3.13528106 |
| 115 | negative regulation of tissue remodeling (GO:0034104) | 3.12735853 |
| 116 | low-density lipoprotein particle remodeling (GO:0034374) | 3.12260599 |
| 117 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 3.11203953 |
| 118 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 3.11203953 |
| 119 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.10989199 |
| 120 | sterol biosynthetic process (GO:0016126) | 3.10263592 |
| 121 | lung epithelium development (GO:0060428) | 3.08887494 |
| 122 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.08393509 |
| 123 | positive regulation of insulin secretion (GO:0032024) | 3.06621094 |
| 124 | negative regulation of cyclic nucleotide metabolic process (GO:0030800) | 3.02283115 |
| 125 | drinking behavior (GO:0042756) | 2.98097425 |
| 126 | cyclic-nucleotide-mediated signaling (GO:0019935) | 2.96825964 |
| 127 | glutamate metabolic process (GO:0006536) | 2.95184477 |
| 128 | synaptic vesicle maturation (GO:0016188) | 2.95089483 |
| 129 | response to dietary excess (GO:0002021) | 2.94264886 |
| 130 | positive regulation of amino acid transport (GO:0051957) | 2.93429708 |
| 131 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.93363532 |
| 132 | hyperosmotic salinity response (GO:0042538) | 2.92324184 |
| 133 | sodium ion homeostasis (GO:0055078) | 2.92106132 |
| 134 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.91816451 |
| 135 | negative regulation of norepinephrine secretion (GO:0010700) | 2.90519164 |
| 136 | regulation of adenylate cyclase activity (GO:0045761) | 2.90516217 |
| 137 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.90360804 |
| 138 | lipid homeostasis (GO:0055088) | 2.89320868 |
| 139 | cell communication involved in cardiac conduction (GO:0086065) | 2.88939638 |
| 140 | membrane repolarization during action potential (GO:0086011) | 2.88046438 |
| 141 | regulation of hexokinase activity (GO:1903299) | 2.87856103 |
| 142 | regulation of glucokinase activity (GO:0033131) | 2.87856103 |
| 143 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.87517639 |
| 144 | neurotransmitter secretion (GO:0007269) | 2.86132662 |
| 145 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.85805008 |
| 146 | endocrine pancreas development (GO:0031018) | 2.85790434 |
| 147 | protein maturation by protein folding (GO:0022417) | 2.85401991 |
| 148 | positive regulation of potassium ion transport (GO:0043268) | 2.83522609 |
| 149 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.83129536 |
| 150 | response to auditory stimulus (GO:0010996) | 2.82625030 |
| 151 | insulin secretion (GO:0030073) | 2.82306413 |
| 152 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.81879034 |
| 153 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.81623466 |
| 154 | amino acid import (GO:0043090) | 2.81304057 |
| 155 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.81299792 |
| 156 | positive regulation of urine volume (GO:0035810) | 2.80613097 |
| 157 | neuromuscular process controlling posture (GO:0050884) | 2.80182210 |
| 158 | L-ascorbic acid metabolic process (GO:0019852) | 2.80016412 |
| 159 | potassium ion export (GO:0071435) | 2.79714481 |
| 160 | locomotory exploration behavior (GO:0035641) | 2.79237023 |
| 161 | regulation of norepinephrine secretion (GO:0014061) | 2.78944417 |
| 162 | cerebellar granule cell differentiation (GO:0021707) | 2.78162436 |
| 163 | cellular response to cholesterol (GO:0071397) | 2.77904042 |
| 164 | regulation of insulin secretion (GO:0050796) | 2.76944191 |
| 165 | peristalsis (GO:0030432) | 2.76609258 |
| 166 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.74910238 |
| 167 | cellular zinc ion homeostasis (GO:0006882) | 2.74808908 |
| 168 | renal tubule morphogenesis (GO:0061333) | 2.73138716 |
| 169 | vasoconstriction (GO:0042310) | 2.72428620 |
| 170 | fatty acid homeostasis (GO:0055089) | 2.72174623 |
| 171 | melanocyte differentiation (GO:0030318) | 2.71191895 |
| 172 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.70038746 |
| 173 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.70038746 |
| 174 | neurotransmitter transport (GO:0006836) | 2.69926754 |
| 175 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.68481359 |
| 176 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.67967988 |
| 177 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.67252523 |
| 178 | nephron epithelium morphogenesis (GO:0072088) | 2.67107184 |
| 179 | nephron tubule morphogenesis (GO:0072078) | 2.67107184 |
| 180 | regulation of excretion (GO:0044062) | 2.66401727 |
| 181 | tonic smooth muscle contraction (GO:0014820) | 2.65724003 |
| 182 | detection of calcium ion (GO:0005513) | 2.65595296 |
| 183 | exocrine pancreas development (GO:0031017) | 2.64680117 |
| 184 | phospholipid homeostasis (GO:0055091) | 2.62809574 |
| 185 | serine family amino acid catabolic process (GO:0009071) | 2.61730900 |
| 186 | aromatic amino acid family catabolic process (GO:0009074) | 2.60397377 |
| 187 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.59891221 |
| 188 | anion homeostasis (GO:0055081) | 2.54994251 |
| 189 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.54503852 |
| 190 | cellular anion homeostasis (GO:0030002) | 2.52905692 |
| 191 | proline biosynthetic process (GO:0006561) | 2.51512636 |
| 192 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 2.49693824 |
| 193 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.47737025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.62269755 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.26122286 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.41525388 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.90046507 |
| 5 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.08006880 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.95523006 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.93485493 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.88468164 |
| 9 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.78339885 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.75843161 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.64122862 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.56456640 |
| 13 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.53333194 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52933093 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.42217787 |
| 16 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.41844230 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.37412705 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36224911 |
| 19 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.35437761 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.31688377 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.25806332 |
| 22 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.22616858 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.20667279 |
| 24 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.19174838 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19010326 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.18393124 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.16487146 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13473697 |
| 29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.10313223 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.10099979 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.05983213 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.05983213 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.02359929 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.01573815 |
| 35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00264162 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90716450 |
| 37 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.87835566 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.85185898 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.84964608 |
| 40 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.75745321 |
| 41 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73567076 |
| 42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.72599336 |
| 43 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.71216844 |
| 44 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.68497802 |
| 45 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.64326318 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.62956207 |
| 47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.52035327 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.50947435 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50432258 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48403042 |
| 51 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.47330938 |
| 52 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.44595178 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44188720 |
| 54 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.44016654 |
| 55 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.43008526 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39952945 |
| 57 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38753531 |
| 58 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38689075 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.38485429 |
| 60 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37940815 |
| 61 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34425448 |
| 62 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.33827223 |
| 63 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.33827223 |
| 64 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.33827223 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33673115 |
| 66 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31907549 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31544004 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.30980930 |
| 69 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.30867863 |
| 70 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30413125 |
| 71 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.30339260 |
| 72 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.30315656 |
| 73 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28458299 |
| 74 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25721848 |
| 75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24887447 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22977685 |
| 77 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.22652878 |
| 78 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.22273413 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21043350 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18100540 |
| 81 | AR_19668381_ChIP-Seq_PC3_Human | 1.17896875 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17082539 |
| 83 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.16637965 |
| 84 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.16024847 |
| 85 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.14218873 |
| 86 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13930357 |
| 87 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12755978 |
| 88 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12573016 |
| 89 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12085882 |
| 90 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11572205 |
| 91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.09867557 |
| 92 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08605214 |
| 93 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07389755 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07267238 |
| 95 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06813487 |
| 96 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.06614017 |
| 97 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.06407872 |
| 98 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.06101211 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.06048104 |
| 100 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05871407 |
| 101 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05522842 |
| 102 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.05184974 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04938098 |
| 104 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04562630 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04435442 |
| 106 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03710508 |
| 107 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03710508 |
| 108 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03527432 |
| 109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.01985687 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00145043 |
| 111 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.98949517 |
| 112 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.98927586 |
| 113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98602505 |
| 114 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.98485050 |
| 115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97530687 |
| 116 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97178143 |
| 117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96432102 |
| 118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.96113892 |
| 119 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.95702836 |
| 120 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95351783 |
| 121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95083956 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95043071 |
| 123 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.94777027 |
| 124 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94746814 |
| 125 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.94050004 |
| 126 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93837122 |
| 127 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.92721737 |
| 128 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92568515 |
| 129 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92523007 |
| 130 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92021674 |
| 131 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92017677 |
| 132 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91614264 |
| 133 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91574165 |
| 134 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91392529 |
| 135 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.91253872 |
| 136 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90908080 |
| 137 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90858201 |
| 138 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90806357 |
| 139 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90308202 |
| 140 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89983532 |
| 141 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.89599905 |
| 142 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88926762 |
| 143 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87894724 |
| 144 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.87824583 |
| 145 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87771913 |
| 146 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87234935 |
| 147 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86499694 |
| 148 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85531696 |
| 149 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.85450259 |
| 150 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.84543331 |
| 151 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.81260857 |
| 152 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.81210908 |
| 153 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.80925782 |
| 154 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.80582235 |
| 155 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.80499423 |
| 156 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80233897 |
| 157 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79898880 |
| 158 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78961159 |
| 159 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.78961159 |
| 160 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78724026 |
| 161 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.78278864 |
| 162 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.77552279 |
| 163 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.76834534 |
| 164 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.76202875 |
| 165 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75625206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 8.04684092 |
| 2 | MP0005171_absent_coat_pigmentation | 5.33800416 |
| 3 | MP0003195_calcinosis | 4.07826084 |
| 4 | MP0005360_urolithiasis | 3.75274801 |
| 5 | MP0003122_maternal_imprinting | 3.34219040 |
| 6 | MP0005365_abnormal_bile_salt | 3.07599920 |
| 7 | MP0004043_abnormal_pH_regulation | 3.03670843 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.01004274 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.98602463 |
| 10 | MP0004858_abnormal_nervous_system | 2.91632914 |
| 11 | MP0003283_abnormal_digestive_organ | 2.76641906 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.56311297 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.52229248 |
| 14 | MP0000566_synostosis | 2.34714500 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 2.33041055 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.28426349 |
| 17 | MP0004270_analgesia | 2.25395944 |
| 18 | MP0004859_abnormal_synaptic_plasticity | 2.23871276 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.23487230 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.21867885 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 2.15214848 |
| 22 | MP0002909_abnormal_adrenal_gland | 2.06782925 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 2.03568672 |
| 24 | MP0001529_abnormal_vocalization | 1.97256452 |
| 25 | MP0002938_white_spotting | 1.91451087 |
| 26 | MP0002653_abnormal_ependyma_morphology | 1.90103823 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.88762657 |
| 28 | MP0009046_muscle_twitch | 1.85078503 |
| 29 | MP0003890_abnormal_embryonic-extraembry | 1.78606320 |
| 30 | MP0009745_abnormal_behavioral_response | 1.71039787 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.68924022 |
| 32 | MP0003567_abnormal_fetal_cardiomyocyte | 1.67258327 |
| 33 | MP0003123_paternal_imprinting | 1.66885765 |
| 34 | MP0003880_abnormal_central_pattern | 1.64574884 |
| 35 | MP0003121_genomic_imprinting | 1.64202715 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.61036867 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.59994210 |
| 38 | MP0003690_abnormal_glial_cell | 1.57714841 |
| 39 | MP0002064_seizures | 1.53619132 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.52342510 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.51899379 |
| 42 | MP0002254_reproductive_system_inflammat | 1.49793521 |
| 43 | MP0002063_abnormal_learning/memory/cond | 1.46785482 |
| 44 | MP0001440_abnormal_grooming_behavior | 1.46096389 |
| 45 | MP0006072_abnormal_retinal_apoptosis | 1.45916053 |
| 46 | MP0004885_abnormal_endolymph | 1.44901964 |
| 47 | MP0004133_heterotaxia | 1.44874381 |
| 48 | MP0002693_abnormal_pancreas_physiology | 1.42135690 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.38102858 |
| 50 | MP0003787_abnormal_imprinting | 1.38044522 |
| 51 | MP0005408_hypopigmentation | 1.37979749 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.37801686 |
| 53 | MP0001270_distended_abdomen | 1.37675858 |
| 54 | MP0001293_anophthalmia | 1.36632325 |
| 55 | MP0005332_abnormal_amino_acid | 1.34698931 |
| 56 | MP0008877_abnormal_DNA_methylation | 1.34237790 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.33291559 |
| 58 | MP0002272_abnormal_nervous_system | 1.32881436 |
| 59 | MP0009840_abnormal_foam_cell | 1.32513603 |
| 60 | MP0004215_abnormal_myocardial_fiber | 1.32423056 |
| 61 | MP0005377_hearing/vestibular/ear_phenot | 1.31108935 |
| 62 | MP0003878_abnormal_ear_physiology | 1.31108935 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.30203393 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 1.29879010 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.27799641 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.24662121 |
| 67 | MP0002734_abnormal_mechanical_nocicepti | 1.24133638 |
| 68 | MP0003942_abnormal_urinary_system | 1.22663470 |
| 69 | MP0001944_abnormal_pancreas_morphology | 1.22608461 |
| 70 | MP0003011_delayed_dark_adaptation | 1.22039605 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.21706428 |
| 72 | MP0001486_abnormal_startle_reflex | 1.20859030 |
| 73 | MP0001970_abnormal_pain_threshold | 1.20381922 |
| 74 | MP0002118_abnormal_lipid_homeostasis | 1.19840687 |
| 75 | MP0001968_abnormal_touch/_nociception | 1.19424422 |
| 76 | MP0003329_amyloid_beta_deposits | 1.16168825 |
| 77 | MP0002733_abnormal_thermal_nociception | 1.15881439 |
| 78 | MP0004142_abnormal_muscle_tone | 1.15445025 |
| 79 | MP0006276_abnormal_autonomic_nervous | 1.15270699 |
| 80 | MP0003646_muscle_fatigue | 1.14627216 |
| 81 | MP0005379_endocrine/exocrine_gland_phen | 1.14364507 |
| 82 | MP0003137_abnormal_impulse_conducting | 1.12664083 |
| 83 | MP0003868_abnormal_feces_composition | 1.12519757 |
| 84 | MP0000639_abnormal_adrenal_gland | 1.12320341 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 1.11089709 |
| 86 | MP0006292_abnormal_olfactory_placode | 1.10916754 |
| 87 | MP0003252_abnormal_bile_duct | 1.10084270 |
| 88 | MP0002751_abnormal_autonomic_nervous | 1.09898236 |
| 89 | MP0003633_abnormal_nervous_system | 1.09052477 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 1.09006495 |
| 91 | MP0003879_abnormal_hair_cell | 1.08759781 |
| 92 | MP0002163_abnormal_gland_morphology | 1.08516728 |
| 93 | MP0001905_abnormal_dopamine_level | 1.05285081 |
| 94 | MP0004233_abnormal_muscle_weight | 1.04980505 |
| 95 | MP0002067_abnormal_sensory_capabilities | 1.04838791 |
| 96 | MP0004924_abnormal_behavior | 1.03854849 |
| 97 | MP0005386_behavior/neurological_phenoty | 1.03854849 |
| 98 | MP0002160_abnormal_reproductive_system | 1.03512174 |
| 99 | MP0006054_spinal_hemorrhage | 1.03406345 |
| 100 | MP0004085_abnormal_heartbeat | 1.01098533 |
| 101 | MP0003634_abnormal_glial_cell | 1.00739608 |
| 102 | MP0002557_abnormal_social/conspecific_i | 1.00679323 |
| 103 | MP0000751_myopathy | 1.00557153 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.99892959 |
| 105 | MP0010368_abnormal_lymphatic_system | 0.99539338 |
| 106 | MP0002233_abnormal_nose_morphology | 0.97657553 |
| 107 | MP0001664_abnormal_digestion | 0.97606456 |
| 108 | MP0001915_intracranial_hemorrhage | 0.96702858 |
| 109 | MP0004019_abnormal_vitamin_homeostasis | 0.95995629 |
| 110 | MP0008569_lethality_at_weaning | 0.95449530 |
| 111 | MP0005636_abnormal_mineral_homeostasis | 0.95389078 |
| 112 | MP0003941_abnormal_skin_development | 0.95344829 |
| 113 | MP0005253_abnormal_eye_physiology | 0.95295467 |
| 114 | MP0003937_abnormal_limbs/digits/tail_de | 0.95175185 |
| 115 | MP0001286_abnormal_eye_development | 0.95021414 |
| 116 | MP0002089_abnormal_postnatal_growth/wei | 0.94522073 |
| 117 | MP0002736_abnormal_nociception_after | 0.93031633 |
| 118 | MP0000631_abnormal_neuroendocrine_gland | 0.92078156 |
| 119 | MP0004264_abnormal_extraembryonic_tissu | 0.91792733 |
| 120 | MP0005220_abnormal_exocrine_pancreas | 0.89238453 |
| 121 | MP0003119_abnormal_digestive_system | 0.88222659 |
| 122 | MP0003631_nervous_system_phenotype | 0.87186686 |
| 123 | MP0003075_altered_response_to | 0.87151168 |
| 124 | MP0001324_abnormal_eye_pigmentation | 0.85192385 |
| 125 | MP0005535_abnormal_body_temperature | 0.83924352 |
| 126 | MP0000609_abnormal_liver_physiology | 0.83802058 |
| 127 | MP0000462_abnormal_digestive_system | 0.82382504 |
| 128 | MP0000678_abnormal_parathyroid_gland | 0.81608531 |
| 129 | MP0003718_maternal_effect | 0.81486396 |
| 130 | MP0002229_neurodegeneration | 0.81074223 |
| 131 | MP0002090_abnormal_vision | 0.79792091 |
| 132 | MP0003115_abnormal_respiratory_system | 0.79715825 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.79137604 |
| 134 | MP0002972_abnormal_cardiac_muscle | 0.78623590 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.78203683 |
| 136 | MP0000955_abnormal_spinal_cord | 0.77981637 |
| 137 | MP0003938_abnormal_ear_development | 0.77977126 |
| 138 | MP0003953_abnormal_hormone_level | 0.77872384 |
| 139 | MP0002822_catalepsy | 0.77571230 |
| 140 | MP0004145_abnormal_muscle_electrophysio | 0.74743587 |
| 141 | MP0001963_abnormal_hearing_physiology | 0.74408770 |
| 142 | MP0005410_abnormal_fertilization | 0.73052631 |
| 143 | MP0008961_abnormal_basal_metabolism | 0.72661158 |
| 144 | MP0005330_cardiomyopathy | 0.72359687 |
| 145 | MP0001756_abnormal_urination | 0.72030324 |
| 146 | MP0002132_abnormal_respiratory_system | 0.71534827 |
| 147 | MP0003315_abnormal_perineum_morphology | 0.71173626 |
| 148 | MP0002066_abnormal_motor_capabilities/c | 0.70556769 |
| 149 | MP0001485_abnormal_pinna_reflex | 0.70476823 |
| 150 | MP0002127_abnormal_cardiovascular_syste | 0.70411543 |
| 151 | MP0005391_vision/eye_phenotype | 0.70227376 |
| 152 | MP0003632_abnormal_nervous_system | 0.68631086 |
| 153 | MP0002092_abnormal_eye_morphology | 0.68377804 |
| 154 | MP0002882_abnormal_neuron_morphology | 0.68263109 |
| 155 | MP0002184_abnormal_innervation | 0.68162565 |
| 156 | MP0002697_abnormal_eye_size | 0.67682538 |
| 157 | MP0004036_abnormal_muscle_relaxation | 0.67398170 |
| 158 | MP0000750_abnormal_muscle_regeneration | 0.67206787 |
| 159 | MP0001984_abnormal_olfaction | 0.66900996 |
| 160 | MP0000003_abnormal_adipose_tissue | 0.66661733 |
| 161 | MP0005195_abnormal_posterior_eye | 0.65558558 |
| 162 | MP0001764_abnormal_homeostasis | 0.61916043 |
| 163 | MP0003698_abnormal_male_reproductive | 0.60921518 |
| 164 | MP0003943_abnormal_hepatobiliary_system | 0.58944826 |
| 165 | MP0001299_abnormal_eye_distance/ | 0.58230596 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.99562390 |
| 2 | Large for gestational age (HP:0001520) | 7.49528557 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 6.35300275 |
| 4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.30218677 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 5.48512672 |
| 6 | Joint hemorrhage (HP:0005261) | 4.72734502 |
| 7 | Hypoglycemic seizures (HP:0002173) | 4.68897331 |
| 8 | Hypothermia (HP:0002045) | 4.45265718 |
| 9 | Abnormal auditory evoked potentials (HP:0006958) | 4.39708128 |
| 10 | Hypoglycemic coma (HP:0001325) | 4.32884812 |
| 11 | Blue irides (HP:0000635) | 4.19774917 |
| 12 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.19147159 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.14206800 |
| 14 | Hepatoblastoma (HP:0002884) | 4.13037209 |
| 15 | Broad alveolar ridges (HP:0000187) | 4.00337462 |
| 16 | Ketoacidosis (HP:0001993) | 3.84717726 |
| 17 | White forelock (HP:0002211) | 3.81203844 |
| 18 | Symptomatic seizures (HP:0011145) | 3.80741811 |
| 19 | Spontaneous abortion (HP:0005268) | 3.76042839 |
| 20 | Hypolipoproteinemia (HP:0010981) | 3.64098596 |
| 21 | Hemiparesis (HP:0001269) | 3.60487632 |
| 22 | Spastic paraparesis (HP:0002313) | 3.45080614 |
| 23 | Xanthomatosis (HP:0000991) | 3.43516738 |
| 24 | Patchy hypopigmentation of hair (HP:0011365) | 3.41703951 |
| 25 | Hypercholesterolemia (HP:0003124) | 3.40109188 |
| 26 | Abnormality of the nasal septum (HP:0000419) | 3.27473522 |
| 27 | Epidermoid cyst (HP:0200040) | 3.23367789 |
| 28 | Pheochromocytoma (HP:0002666) | 3.20312597 |
| 29 | Albinism (HP:0001022) | 3.20165272 |
| 30 | Increased serum pyruvate (HP:0003542) | 3.19872019 |
| 31 | Hypopigmentation of the fundus (HP:0007894) | 3.16610966 |
| 32 | Complement deficiency (HP:0004431) | 3.15181203 |
| 33 | Acanthocytosis (HP:0001927) | 3.12379170 |
| 34 | Osteomalacia (HP:0002749) | 3.09299239 |
| 35 | Hypoplasia of the fovea (HP:0007750) | 3.09093576 |
| 36 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.09093576 |
| 37 | Paraparesis (HP:0002385) | 3.05460421 |
| 38 | Hyperglycinemia (HP:0002154) | 3.02931649 |
| 39 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.00961041 |
| 40 | Hemiplegia (HP:0002301) | 2.96672862 |
| 41 | Visual hallucinations (HP:0002367) | 2.95650896 |
| 42 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.92219474 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.91857350 |
| 44 | Hyperglycemia (HP:0003074) | 2.88384692 |
| 45 | Abnormality of glycolysis (HP:0004366) | 2.87067815 |
| 46 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.85481607 |
| 47 | Aplasia of the phalanges of the hand (HP:0009802) | 2.85481607 |
| 48 | Aplasia involving bones of the extremities (HP:0009825) | 2.85481607 |
| 49 | Enlarged kidneys (HP:0000105) | 2.84574683 |
| 50 | Small epiphyses (HP:0010585) | 2.83017668 |
| 51 | Vaginal fistula (HP:0004320) | 2.79013315 |
| 52 | Diplopia (HP:0000651) | 2.78340332 |
| 53 | Abnormality of binocular vision (HP:0011514) | 2.78340332 |
| 54 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.75060412 |
| 55 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.74934085 |
| 56 | Bifid tongue (HP:0010297) | 2.73049547 |
| 57 | Glomerulonephritis (HP:0000099) | 2.70660036 |
| 58 | Abnormality of the fovea (HP:0000493) | 2.70450484 |
| 59 | Supernumerary spleens (HP:0009799) | 2.65118722 |
| 60 | Heterochromia iridis (HP:0001100) | 2.65021915 |
| 61 | Diastasis recti (HP:0001540) | 2.64589692 |
| 62 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.63710727 |
| 63 | Broad palm (HP:0001169) | 2.62968003 |
| 64 | Generalized tonic-clonic seizures (HP:0002069) | 2.62199958 |
| 65 | Abnormal tarsal ossification (HP:0008369) | 2.61734317 |
| 66 | Abnormality of glycine metabolism (HP:0010895) | 2.61031595 |
| 67 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.61031595 |
| 68 | Hyperglycinuria (HP:0003108) | 2.57744308 |
| 69 | Thyroid-stimulating hormone excess (HP:0002925) | 2.53209697 |
| 70 | Maternal diabetes (HP:0009800) | 2.53131801 |
| 71 | Bilateral microphthalmos (HP:0007633) | 2.52094571 |
| 72 | Menorrhagia (HP:0000132) | 2.49135153 |
| 73 | Vascular calcification (HP:0004934) | 2.46210111 |
| 74 | Hypophosphatemic rickets (HP:0004912) | 2.41383969 |
| 75 | Failure to thrive in infancy (HP:0001531) | 2.38217065 |
| 76 | Agitation (HP:0000713) | 2.36507998 |
| 77 | Atonic seizures (HP:0010819) | 2.35160742 |
| 78 | Short middle phalanx of the 5th finger (HP:0004220) | 2.34394043 |
| 79 | Epiphyseal dysplasia (HP:0002656) | 2.33872657 |
| 80 | Hypoalphalipoproteinemia (HP:0003233) | 2.33088928 |
| 81 | Neoplasm of the thyroid gland (HP:0100031) | 2.32745439 |
| 82 | Late onset (HP:0003584) | 2.31318180 |
| 83 | Epileptic encephalopathy (HP:0200134) | 2.29537625 |
| 84 | Focal motor seizures (HP:0011153) | 2.29395099 |
| 85 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.29186316 |
| 86 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.28838569 |
| 87 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.28838569 |
| 88 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.28435787 |
| 89 | Decreased circulating renin level (HP:0003351) | 2.24454533 |
| 90 | Absent eyebrow (HP:0002223) | 2.24191987 |
| 91 | Abnormality of carpal bone ossification (HP:0006257) | 2.22121469 |
| 92 | Irregular epiphyses (HP:0010582) | 2.19340431 |
| 93 | Intrahepatic cholestasis (HP:0001406) | 2.18454516 |
| 94 | Generalized hypopigmentation (HP:0007513) | 2.18385440 |
| 95 | Depression (HP:0000716) | 2.16722533 |
| 96 | Potter facies (HP:0002009) | 2.16630310 |
| 97 | Facial shape deformation (HP:0011334) | 2.16630310 |
| 98 | Generalized aminoaciduria (HP:0002909) | 2.14579681 |
| 99 | Embryonal renal neoplasm (HP:0011794) | 2.14391521 |
| 100 | Megalencephaly (HP:0001355) | 2.11900889 |
| 101 | Tetraplegia (HP:0002445) | 2.11702976 |
| 102 | Abnormal pancreas size (HP:0012094) | 2.07984545 |
| 103 | Intestinal polyposis (HP:0200008) | 2.06821353 |
| 104 | Ketosis (HP:0001946) | 2.06789579 |
| 105 | Increased circulating renin level (HP:0000848) | 2.04677301 |
| 106 | Abnormality of pain sensation (HP:0010832) | 2.02683702 |
| 107 | Impaired pain sensation (HP:0007328) | 2.02683702 |
| 108 | Hemorrhage of the eye (HP:0011885) | 2.02586336 |
| 109 | Abnormality of the vitreous humor (HP:0004327) | 2.01027929 |
| 110 | Cardiovascular calcification (HP:0011915) | 2.00526161 |
| 111 | Anxiety (HP:0000739) | 1.99949452 |
| 112 | Menstrual irregularities (HP:0000858) | 1.99866878 |
| 113 | Rectovaginal fistula (HP:0000143) | 1.98077779 |
| 114 | Rectal fistula (HP:0100590) | 1.98077779 |
| 115 | Abnormality of the wing of the ilium (HP:0011867) | 1.97768933 |
| 116 | Truncal ataxia (HP:0002078) | 1.97474240 |
| 117 | Left ventricular hypertrophy (HP:0001712) | 1.97194552 |
| 118 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.96277941 |
| 119 | Widely patent fontanelles and sutures (HP:0004492) | 1.94198696 |
| 120 | Gout (HP:0001997) | 1.93579852 |
| 121 | Myoglobinuria (HP:0002913) | 1.93525075 |
| 122 | Pigmentary retinal degeneration (HP:0001146) | 1.93348321 |
| 123 | Postural instability (HP:0002172) | 1.92994998 |
| 124 | Absence seizures (HP:0002121) | 1.91860019 |
| 125 | Hypokalemia (HP:0002900) | 1.90864631 |
| 126 | Exercise-induced myalgia (HP:0003738) | 1.89945928 |
| 127 | Scrotal hypoplasia (HP:0000046) | 1.89082061 |
| 128 | EEG with generalized epileptiform discharges (HP:0011198) | 1.88809729 |
| 129 | Focal seizures (HP:0007359) | 1.87751048 |
| 130 | Asymmetry of the thorax (HP:0001555) | 1.87668254 |
| 131 | Abnormality of the alveolar ridges (HP:0006477) | 1.87556883 |
| 132 | Neoplasm of the liver (HP:0002896) | 1.87241145 |
| 133 | Hypsarrhythmia (HP:0002521) | 1.87172107 |
| 134 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.87163014 |
| 135 | Absent epiphyses (HP:0010577) | 1.87163014 |
| 136 | Anophthalmia (HP:0000528) | 1.85888505 |
| 137 | Intestinal polyp (HP:0005266) | 1.85197701 |
| 138 | Retinal atrophy (HP:0001105) | 1.85041681 |
| 139 | Prolonged QT interval (HP:0001657) | 1.84642192 |
| 140 | Proximal tubulopathy (HP:0000114) | 1.84288515 |
| 141 | Epileptiform EEG discharges (HP:0011182) | 1.84193148 |
| 142 | Abnormality of the labia minora (HP:0012880) | 1.83133475 |
| 143 | Neurofibrillary tangles (HP:0002185) | 1.82607871 |
| 144 | Alacrima (HP:0000522) | 1.82454397 |
| 145 | Polyphagia (HP:0002591) | 1.82339909 |
| 146 | Hyperparathyroidism (HP:0000843) | 1.80571234 |
| 147 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.79907652 |
| 148 | Striae distensae (HP:0001065) | 1.79808972 |
| 149 | Absent eyelashes (HP:0000561) | 1.79206780 |
| 150 | Absent hair (HP:0002298) | 1.78842106 |
| 151 | Prenatal maternal abnormality (HP:0002686) | 1.78433839 |
| 152 | Narrow nasal bridge (HP:0000446) | 1.77910961 |
| 153 | Atrial fibrillation (HP:0005110) | 1.77202426 |
| 154 | Abnormal EKG (HP:0003115) | 1.76428438 |
| 155 | Neoplasm of the heart (HP:0100544) | 1.75599567 |
| 156 | Dialeptic seizures (HP:0011146) | 1.74139682 |
| 157 | Arthropathy (HP:0003040) | 1.74115388 |
| 158 | Hypoplastic left heart (HP:0004383) | 1.73893916 |
| 159 | Embryonal neoplasm (HP:0002898) | 1.73745310 |
| 160 | Wide nose (HP:0000445) | 1.73739419 |
| 161 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.73715683 |
| 162 | Fat malabsorption (HP:0002630) | 1.73657624 |
| 163 | Status epilepticus (HP:0002133) | 1.73523213 |
| 164 | Adducted thumb (HP:0001181) | 1.72908380 |
| 165 | Abnormality of renin-angiotensin system (HP:0000847) | 1.72780163 |
| 166 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.72344626 |
| 167 | Postural tremor (HP:0002174) | 1.72272602 |
| 168 | Poor suck (HP:0002033) | 1.72261132 |
| 169 | Supranuclear gaze palsy (HP:0000605) | 1.72124608 |
| 170 | Atrioventricular block (HP:0001678) | 1.70669002 |
| 171 | Decreased muscle mass (HP:0003199) | 1.70122789 |
| 172 | Meckel diverticulum (HP:0002245) | 1.69428920 |
| 173 | Abnormality of the ileum (HP:0001549) | 1.67991490 |
| 174 | Abnormality of the pubic bones (HP:0003172) | 1.66323521 |
| 175 | Abnormality of complement system (HP:0005339) | 1.66026527 |
| 176 | Myelomeningocele (HP:0002475) | 1.60806875 |
| 177 | Intestinal fistula (HP:0100819) | 1.59315426 |
| 178 | Gingival bleeding (HP:0000225) | 1.59168954 |
| 179 | Abnormality of the intrinsic pathway (HP:0010989) | 1.58961256 |
| 180 | Hypomagnesemia (HP:0002917) | 1.58616118 |
| 181 | Renal duplication (HP:0000075) | 1.57506081 |
| 182 | Malignant hyperthermia (HP:0002047) | 1.56886036 |
| 183 | Hepatocellular carcinoma (HP:0001402) | 1.55880846 |
| 184 | Gonadal dysgenesis (HP:0000133) | 1.54912915 |
| 185 | Bronchomalacia (HP:0002780) | 1.54627568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRKD3 | 5.72383731 |
| 2 | FGFR4 | 4.76024417 |
| 3 | NTRK3 | 4.42065608 |
| 4 | INSRR | 3.83448703 |
| 5 | FGFR3 | 3.50184609 |
| 6 | FGFR2 | 3.29125554 |
| 7 | AKT3 | 3.00590400 |
| 8 | TNIK | 2.77793453 |
| 9 | LMTK2 | 2.73231925 |
| 10 | PASK | 2.68059817 |
| 11 | MAPK15 | 2.61189132 |
| 12 | NTRK2 | 2.43040124 |
| 13 | MAP2K7 | 2.33950671 |
| 14 | PHKG2 | 2.28177354 |
| 15 | PHKG1 | 2.28177354 |
| 16 | MAP3K4 | 2.18064572 |
| 17 | TYRO3 | 2.14723544 |
| 18 | BMPR1B | 2.08207759 |
| 19 | FGFR1 | 1.98249258 |
| 20 | PIK3CA | 1.94309798 |
| 21 | FRK | 1.79152209 |
| 22 | GRK5 | 1.77353000 |
| 23 | HIPK2 | 1.72096181 |
| 24 | MAPK13 | 1.71986133 |
| 25 | SGK2 | 1.67174540 |
| 26 | STK16 | 1.63823785 |
| 27 | NTRK1 | 1.61072919 |
| 28 | ARAF | 1.59247873 |
| 29 | BRAF | 1.58691507 |
| 30 | BCR | 1.56625892 |
| 31 | ERN1 | 1.54642863 |
| 32 | MARK1 | 1.54555126 |
| 33 | LATS1 | 1.48152386 |
| 34 | PAK3 | 1.47753948 |
| 35 | MAP4K2 | 1.46833285 |
| 36 | ALK | 1.42444931 |
| 37 | MAP2K4 | 1.40689407 |
| 38 | PRKCH | 1.39600865 |
| 39 | SGK494 | 1.38717719 |
| 40 | SGK223 | 1.38717719 |
| 41 | CDK8 | 1.34036732 |
| 42 | ICK | 1.32601869 |
| 43 | WNK4 | 1.31485711 |
| 44 | PRKD2 | 1.31312018 |
| 45 | NUAK1 | 1.30872727 |
| 46 | DYRK2 | 1.30309707 |
| 47 | GRK7 | 1.28350058 |
| 48 | PINK1 | 1.28163201 |
| 49 | ZAK | 1.27310410 |
| 50 | MAP3K9 | 1.26897861 |
| 51 | SIK2 | 1.22654377 |
| 52 | UHMK1 | 1.21287563 |
| 53 | CDC42BPA | 1.20536796 |
| 54 | PLK3 | 1.20174461 |
| 55 | TRIM28 | 1.18594589 |
| 56 | SGK3 | 1.17428938 |
| 57 | DYRK1B | 1.16102623 |
| 58 | PRKCG | 1.13603529 |
| 59 | DAPK2 | 1.11153697 |
| 60 | PRKCE | 1.09829551 |
| 61 | MINK1 | 1.05430806 |
| 62 | MAP3K2 | 1.04242004 |
| 63 | WNK1 | 1.03322732 |
| 64 | MUSK | 1.01515171 |
| 65 | CSNK1G1 | 0.97083442 |
| 66 | ADRBK2 | 0.93470461 |
| 67 | MAPK7 | 0.92910670 |
| 68 | CSNK1E | 0.92396100 |
| 69 | ERBB2 | 0.90462244 |
| 70 | STK39 | 0.89356702 |
| 71 | CSNK1A1L | 0.88705116 |
| 72 | DYRK3 | 0.86838388 |
| 73 | MKNK2 | 0.85841450 |
| 74 | EIF2AK3 | 0.82627912 |
| 75 | MAPK12 | 0.78588054 |
| 76 | CSNK1D | 0.78299536 |
| 77 | CDK5 | 0.77348193 |
| 78 | GRK1 | 0.76748046 |
| 79 | ADRBK1 | 0.75173403 |
| 80 | SGK1 | 0.73712166 |
| 81 | MAP3K7 | 0.72456714 |
| 82 | MAP3K1 | 0.71766554 |
| 83 | NEK1 | 0.71515604 |
| 84 | CAMK2D | 0.69027560 |
| 85 | MAP3K6 | 0.68992733 |
| 86 | CAMK2A | 0.68892865 |
| 87 | CSNK1G3 | 0.68433795 |
| 88 | SRPK1 | 0.68136203 |
| 89 | STK38L | 0.67993741 |
| 90 | CASK | 0.65627511 |
| 91 | MAP3K5 | 0.64585572 |
| 92 | RIPK1 | 0.64320949 |
| 93 | PRKCZ | 0.63553002 |
| 94 | EIF2AK1 | 0.63332056 |
| 95 | PAK6 | 0.63270572 |
| 96 | SCYL2 | 0.61527456 |
| 97 | CSNK1G2 | 0.61479429 |
| 98 | CAMK2G | 0.61129732 |
| 99 | TSSK6 | 0.60472441 |
| 100 | PLK2 | 0.59552812 |
| 101 | PLK4 | 0.59395159 |
| 102 | MKNK1 | 0.58336511 |
| 103 | NME1 | 0.58267358 |
| 104 | PDGFRA | 0.57719061 |
| 105 | ATM | 0.57525238 |
| 106 | PRKACG | 0.56400968 |
| 107 | MELK | 0.56239890 |
| 108 | PRPF4B | 0.55955036 |
| 109 | PRKD1 | 0.54220829 |
| 110 | RET | 0.53800546 |
| 111 | CDK7 | 0.53787518 |
| 112 | BCKDK | 0.52896281 |
| 113 | NEK6 | 0.52834230 |
| 114 | CDK12 | 0.51090914 |
| 115 | PRKACA | 0.50791954 |
| 116 | BRSK1 | 0.48100773 |
| 117 | CAMK2B | 0.46658559 |
| 118 | WNK3 | 0.46378465 |
| 119 | MET | 0.46056714 |
| 120 | ATR | 0.45653831 |
| 121 | IRAK2 | 0.45551824 |
| 122 | IGF1R | 0.45429464 |
| 123 | PLK1 | 0.42289915 |
| 124 | MARK2 | 0.41638539 |
| 125 | MAPK10 | 0.40907199 |
| 126 | TTK | 0.40445161 |
| 127 | RPS6KA3 | 0.39847874 |
| 128 | CSNK2A1 | 0.39324624 |
| 129 | CSNK2A2 | 0.38839949 |
| 130 | PRKCA | 0.38701498 |
| 131 | PDK2 | 0.38605200 |
| 132 | STK38 | 0.38143976 |
| 133 | PRKAA1 | 0.38029046 |
| 134 | PBK | 0.37697809 |
| 135 | KSR2 | 0.37686589 |
| 136 | VRK1 | 0.37020383 |
| 137 | TNK2 | 0.35890249 |
| 138 | DYRK1A | 0.33973344 |
| 139 | OBSCN | 0.31979425 |
| 140 | PRKCI | 0.30781859 |
| 141 | LATS2 | 0.29281450 |
| 142 | PKN1 | 0.28244657 |
| 143 | PRKG1 | 0.28187334 |
| 144 | RPS6KB1 | 0.27238323 |
| 145 | PRKDC | 0.26320622 |
| 146 | EPHA4 | 0.25522196 |
| 147 | NLK | 0.25130827 |
| 148 | PRKAA2 | 0.25059992 |
| 149 | SIK1 | 0.24962020 |
| 150 | CAMKK1 | 0.24897286 |
| 151 | CSNK1A1 | 0.24657141 |
| 152 | FER | 0.24352211 |
| 153 | PRKACB | 0.24315047 |
| 154 | RPS6KA2 | 0.24056736 |
| 155 | PRKCB | 0.23971341 |
| 156 | GRK6 | 0.23435108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.44112810 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.64608923 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.56556390 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 2.98960485 |
| 5 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.80395126 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.75994223 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.71283130 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.58074545 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44890178 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.38511108 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.37065682 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.29126504 |
| 13 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.28826346 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.25598316 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.19552492 |
| 16 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.13779930 |
| 17 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.11996700 |
| 18 | Protein export_Homo sapiens_hsa03060 | 2.10580862 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.04579363 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.95641507 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.91126209 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.86778140 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83639941 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.80808313 |
| 25 | Circadian entrainment_Homo sapiens_hsa04713 | 1.79546515 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.74904391 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.73860778 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.71926777 |
| 29 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.67856748 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.67728577 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66860995 |
| 32 | Morphine addiction_Homo sapiens_hsa05032 | 1.64040037 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62170113 |
| 34 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.61239721 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.60988569 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.58780431 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.58738681 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.58343401 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.57203975 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.54252116 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.50540431 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.49828583 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.49166059 |
| 44 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.47902016 |
| 45 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.47865019 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.47390024 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 1.36958674 |
| 48 | Salivary secretion_Homo sapiens_hsa04970 | 1.35375139 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.35336096 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33874742 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33558406 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.32289221 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.31964854 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.25715723 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.22474481 |
| 56 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.22462609 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.21040441 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.20086649 |
| 59 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.19326314 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.18160523 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15780798 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.14086090 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13661070 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12533167 |
| 65 | Melanogenesis_Homo sapiens_hsa04916 | 1.10086068 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.03273058 |
| 67 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.02880740 |
| 68 | ABC transporters_Homo sapiens_hsa02010 | 1.01060411 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00124714 |
| 70 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99970138 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99755448 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.99664670 |
| 73 | Long-term depression_Homo sapiens_hsa04730 | 0.99059071 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98433373 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96552128 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96334011 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 0.95625211 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92428438 |
| 79 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89671969 |
| 80 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89654384 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88338128 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.88323475 |
| 83 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86866645 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.86642373 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86456818 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.85560567 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85500244 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.85260135 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.83973409 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81978470 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81851647 |
| 92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80597436 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80056688 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78797786 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78491089 |
| 96 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.78396676 |
| 97 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.75808113 |
| 98 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74661918 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74459566 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.73992670 |
| 101 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72416724 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.71692738 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.71028362 |
| 104 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.70737172 |
| 105 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70187828 |
| 106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68436056 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.65959928 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65113050 |
| 109 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.63957865 |
| 110 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62310833 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61806228 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59923782 |
| 113 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59701264 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59526007 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.58580625 |
| 116 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58198445 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57354767 |
| 118 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55999730 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54708551 |
| 120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54164120 |
| 121 | Other glycan degradation_Homo sapiens_hsa00511 | 0.53988994 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53108485 |
| 123 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.52608592 |
| 124 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51610423 |
| 125 | Insulin resistance_Homo sapiens_hsa04931 | 0.51331852 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51018021 |
| 127 | RNA polymerase_Homo sapiens_hsa03020 | 0.49087085 |
| 128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48454454 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48433658 |
| 130 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48103021 |
| 131 | Phototransduction_Homo sapiens_hsa04744 | 0.48020892 |
| 132 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47061941 |
| 133 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.46890668 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45916603 |
| 135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44349700 |
| 136 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43905878 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43218905 |
| 138 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41895503 |
| 139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41398966 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41077262 |
| 141 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.39540478 |
| 142 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39477186 |
| 143 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38654690 |
| 144 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38274632 |
| 145 | Mineral absorption_Homo sapiens_hsa04978 | 0.38062281 |
| 146 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.37705078 |
| 147 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36548631 |
| 148 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35675601 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34716366 |
| 150 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33971319 |
| 151 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32971217 |
| 152 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.32653132 |
| 153 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.31955249 |
| 154 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31403852 |
| 155 | RNA degradation_Homo sapiens_hsa03018 | 0.30832299 |
| 156 | RNA transport_Homo sapiens_hsa03013 | 0.29278010 |
| 157 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.28443586 |
| 158 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.28384435 |
| 159 | Axon guidance_Homo sapiens_hsa04360 | 0.25423453 |
| 160 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.22659062 |
| 161 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.22381116 |

